Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics - PubMed (original) (raw)
. 2007 May 1;165(9):1076-87.
doi: 10.1093/aje/kwk115. Epub 2007 Mar 10.
Lenore J Launer, Gudny Eiriksdottir, Olafur Kjartansson, Palmi V Jonsson, Gunnar Sigurdsson, Gudmundur Thorgeirsson, Thor Aspelund, Melissa E Garcia, Mary Frances Cotch, Howard J Hoffman, Vilmundur Gudnason
Affiliations
- PMID: 17351290
- PMCID: PMC2723948
- DOI: 10.1093/aje/kwk115
Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics
Tamara B Harris et al. Am J Epidemiol. 2007.
Abstract
In anticipation of the sequencing of the human genome and description of the human proteome, the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik) was initiated in 2002. AGES-Reykjavik was designed to examine risk factors, including genetic susceptibility and gene/environment interaction, in relation to disease and disability in old age. The study is multidisciplinary, providing detailed phenotypes related to the cardiovascular, neurocognitive (including sensory), and musculoskeletal systems, and to body composition and metabolic regulation. Relevant quantitative traits, subclinical indicators of disease, and medical diagnoses are identified by using biomarkers, imaging, and other physiologic indicators. The AGES-Reykjavik sample is drawn from an established population-based cohort, the Reykjavik Study. This cohort of men and women born between 1907 and 1935 has been followed in Iceland since 1967 by the Icelandic Heart Association. The AGES-Reykjavik cohort, with cardiovascular risk factor assessments earlier in life and detailed late-life phenotypes of quantitative traits, will create a comprehensive study of aging nested in a relatively genetically homogeneous older population. This approach should facilitate identification of genetic factors that contribute to healthy aging as well as the chronic conditions common in old age.
Figures
Figure 1. Independence and overlap of prevalent phenotypes in the AGES-Reykjavik Study, 2002–2004
Phenotypes from the Age, Gene/Environment Susceptibility Study (AGES-Reykjavik) are represented by the overlapping circles in this figure, representing the traits of poor cognition, arterial calcification in all areas, high insulin, and low trabecular bone. The phenotypes are further defined in Methods section. Numbers within the circles represent the percent of the cohort with each of these traits. Numbers in areas of overlap indicate the percent of the cohort that has more than one trait. Two percent of the cohort had none of the phenotypes and only 13 percent share all the traits. The number inside the small circle within the ‘poor cognition’ phenotype represents the percent of the cohort which had both poor cognition and low trabecular bone. Similarly, the number inside the small circle within the ‘high insulin’ phenotype represents the portion of the cohort that has both high insulin and arterial calcification in all areas.
Similar articles
- Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-Reykjavik).
Olafsdottir E, Aspelund T, Sigurdsson G, Thorsson B, Benediktsson R, Harris TB, Launer LJ, Eiriksdottir G, Gudnason V. Olafsdottir E, et al. Eur J Epidemiol. 2009;24(6):307-14. doi: 10.1007/s10654-009-9343-x. Epub 2009 May 2. Eur J Epidemiol. 2009. PMID: 19412572 Free PMC article. - Increasing sex difference in bone strength in old age: The Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK).
Sigurdsson G, Aspelund T, Chang M, Jonsdottir B, Sigurdsson S, Eiriksdottir G, Gudmundsson A, Harris TB, Gudnason V, Lang TF. Sigurdsson G, et al. Bone. 2006 Sep;39(3):644-51. doi: 10.1016/j.bone.2006.03.020. Epub 2006 Jun 21. Bone. 2006. PMID: 16790372 - Brain Volume as an Integrated Marker for the Risk of Death in a Community-Based Sample: Age Gene/Environment Susceptibility--Reykjavik Study.
Van Elderen SS, Zhang Q, Sigurdsson S, Haight TJ, Lopez O, Eiriksdottir G, Jonsson P, de Jong L, Harris TB, Garcia M, Gudnason V, van Buchem MA, Launer LJ. Van Elderen SS, et al. J Gerontol A Biol Sci Med Sci. 2016 Jan;71(1):131-7. doi: 10.1093/gerona/glu192. Epub 2014 Oct 30. J Gerontol A Biol Sci Med Sci. 2016. PMID: 25359930 Free PMC article. - Research on aging in Iceland: future potentials.
Gudmundsson A. Gudmundsson A. Mech Ageing Dev. 2004 Feb;125(2):133-5. doi: 10.1016/j.mad.2003.11.009. Mech Ageing Dev. 2004. PMID: 15037018 Review. - Toward the realization of a better aged society: messages from gerontology and geriatrics.
Arai H, Ouchi Y, Yokode M, Ito H, Uematsu H, Eto F, Oshima S, Ota K, Saito Y, Sasaki H, Tsubota K, Fukuyama H, Honda Y, Iguchi A, Toba K, Hosoi T, Kita T; Members of Subcommittee for Aging. Arai H, et al. Geriatr Gerontol Int. 2012 Jan;12(1):16-22. doi: 10.1111/j.1447-0594.2011.00776.x. Geriatr Gerontol Int. 2012. PMID: 22188494 Review.
Cited by
- Computed tomography-based skeletal muscle and adipose tissue attenuation: Variations by age, sex, and muscle.
Figueiredo P, Marques EA, Gudnason V, Lang T, Sigurdsson S, Jonsson PV, Aspelund T, Siggeirsdottir K, Launer L, Eiriksdottir G, Harris TB. Figueiredo P, et al. Exp Gerontol. 2021 Jul 1;149:111306. doi: 10.1016/j.exger.2021.111306. Epub 2021 Mar 10. Exp Gerontol. 2021. PMID: 33713735 Free PMC article. - Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer's disease.
Frick EA, Emilsson V, Jonmundsson T, Steindorsdottir AE, Johnson ECB, Puerta R, Dammer EB, Shantaraman A, Cano A, Boada M, Valero S, García-González P, Gudmundsson EF, Gudjonsson A, Pitts R, Qiu X, Finkel N, Loureiro JJ, Orth AP, Seyfried NT, Levey AI, Ruiz A, Aspelund T, Jennings LL, Launer LJ, Gudmundsdottir V, Gudnason V. Frick EA, et al. Nat Aging. 2024 Oct;4(10):1446-1464. doi: 10.1038/s43587-024-00693-1. Epub 2024 Aug 21. Nat Aging. 2024. PMID: 39169269 Free PMC article. - Effects of a 6-month multimodal training intervention on retention of functional fitness in older adults: a randomized-controlled cross-over design.
Gudlaugsson J, Gudnason V, Aspelund T, Siggeirsdottir K, Olafsdottir AS, Jonsson PV, Arngrimsson SA, Harris TB, Johannsson E. Gudlaugsson J, et al. Int J Behav Nutr Phys Act. 2012 Sep 10;9:107. doi: 10.1186/1479-5868-9-107. Int J Behav Nutr Phys Act. 2012. PMID: 22963328 Free PMC article. Clinical Trial. - Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men.
Sigurdardottir LG, Markt SC, Sigurdsson S, Aspelund T, Fall K, Schernhammer E, Rider JR, Launer L, Harris T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA. Sigurdardottir LG, et al. J Biol Rhythms. 2016 Oct;31(5):461-9. doi: 10.1177/0748730416656948. Epub 2016 Jul 22. J Biol Rhythms. 2016. PMID: 27449477 Free PMC article. - The associations of interstitial lung abnormalities with cancer diagnoses and mortality.
Axelsson GT, Putman RK, Aspelund T, Gudmundsson EF, Hida T, Araki T, Nishino M, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G. Axelsson GT, et al. Eur Respir J. 2020 Dec 17;56(6):1902154. doi: 10.1183/13993003.02154-2019. Print 2020 Dec. Eur Respir J. 2020. PMID: 32646918 Free PMC article.
References
- Freimer N, Sabatti C. The human phenome project. Nat Genet. 2003;34:15–21. - PubMed
- Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340:115–26. - PubMed
- Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245–70. - PubMed
- Festa A, D’Agostino R, Jr, Tracy RP, et al. Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002;51:1131–7. - PubMed
- Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab. 2005;19:547–66. - PubMed
Publication types
MeSH terms
Grants and funding
- N01AG12100/AG/NIA NIH HHS/United States
- N01 AG012100/AG/NIA NIH HHS/United States
- Z99 EY999999/ImNIH/Intramural NIH HHS/United States
- ZIA EY000401-11/ImNIH/Intramural NIH HHS/United States
- Z01 AG007380-02/ImNIH/Intramural NIH HHS/United States
- ZIA EY000401-08/ImNIH/Intramural NIH HHS/United States
- ZIA EY000401-12/ImNIH/Intramural NIH HHS/United States
- ZIA EY000401-15/ImNIH/Intramural NIH HHS/United States
- Z01 EY000401-06/ImNIH/Intramural NIH HHS/United States
- ZIA EY000401-10/ImNIH/Intramural NIH HHS/United States
- ZIA EY000401-09/ImNIH/Intramural NIH HHS/United States
- ZIA EY000401-13/ImNIH/Intramural NIH HHS/United States
- ZIA EY000401-14/ImNIH/Intramural NIH HHS/United States
- Z01 EY000401-07/ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical